2018 Asia-Pacific Immunoprotein Testing Market: A 17-Country Analysis--Supplier Shares, Segment Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Emerging Opportunities

This new report presents analysis of the immunoprotein testing market in 17 countries, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

Country Analyses

Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam

The report provides test volume and sales forecasts by country and market segment for the following assays:

C3
C4
Ceruloplasmin
Free Light Chains
Haptoglobin
IgA
IgE Specific
IgE Total
IgG
IgM
Immunofixation
Prealbumin
Protein Electrophoresis

During the next decade, the immunoprotein testing market will undergo significant transformation. The changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This unique market and technology assessment is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts by country, market segment and individual test; reviews leading analyzers; and profiles key competitors.







Introduction

Worldwide Market and Technology Overview
A. Major Immunoprotein Tests
1. Complement
a. C3
b. C4
2. Free Light Chains
3. Immunofixation
4. Immunoglobulins (IgA, IgE, IgG, IgM)
5. Haptoglobin
6. Prealbumin
7. Protein Electrophoresis
B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC analyzers
manufactured by Abaxis, Abbott, Alere/Inverness,
Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus,
Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox,
Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
C. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors

Country Analyses
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan,
Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore,
South Korea, Taiwan, Thailand, Vietnam
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- bioMerieux
- Bio-Rad
- DiaSorin
- Eiken Chemical
- Fujirebio
- Grifols
- Instrumentation Laboratory/Werfen
- Kyowa Medex
- Ortho-Clinical Diagnostics
- PerkinElmer
- Quest Diagnostics
- Roche
- Siemens Healthineers
- Sysmex
- Thermo Fisher
- Tosoh
- Wako

Hospital Acquired Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

The global hospital acquired disease testing market was worth US$ 752 Million in 2017. Hospital acquired infections (HAIs) or nosocomial infections are diseases that are acquired in hospitals and medical

USD 1999 View Report

Implantable Medical Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

The global implantable medical devices market was worth US$ 90.4 Billion in 2017. Medical implants are devices that are used to replace or act as a fraction for a particular

USD 1999 View Report

2018 Asia-Pacific Diagnostics Market Forecasts for 500 Tests: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM--Competitive Strategies, Opportunities for Suppliers

This new report provides granular analysis of the Asia-Pacific diagnostic testing market, including Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea,

USD 27500 View Report

2018 Asia-Pacific Nucleic Acid Testing (NAT) Analyzers and Reagents Market: A 17-Country Analysis--Supplier Sharesa and Strategies, Test Volume and SalesSegment Forecasts, Technology and Instrumentation Review

This new 17-country report is available by country, market segment, section, or individual test. The report is designed to help current suppliers and potential market entrants identify and evaluate

USD 16500 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available